New vaccine support (NVS) for MEASLESFU
GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems.
- Project ID
47122-18-LBR-36A-X- Activity status
- 2 - Implementation
- Aid type
- B02 - Core contributions to multilateral institutions
- % to Liberia
- 100.00
Organisations
- Funding
- The Global Alliance for Vaccination and Immunisation
- Extending
- World Health Organisation - core voluntary contributions account (for technical assitance)
- Accountable
- Federal States & Local Governments
- Implementing
- Federal States & Local Governments
- Extending
- United Nations Childrens Fund
Disbursements by fiscal year, quarter
| Fiscal year |
Fiscal quarter |
Value (USD) |
Liberia Value (USD) |
| 2017 |
Q3 |
-22,199.00 |
-22,199.00 |
| 2017 |
Q1 |
258,221.00 |
258,221.00 |
Commitments by fiscal year, quarter
| Fiscal year |
Fiscal quarter |
Value (USD) |
Liberia Value (USD) |
| 2017 |
Q3 |
-12,478.00 |
-12,478.00 |
| 2017 |
Q1 |
248,500.00 |
248,500.00 |
MTEF projections by fiscal year
| Fiscal year |
Value (USD) |
Liberia Value (USD) |
| 2018 |
124,250.00 |
124,250.00 |
| 2017 |
124,250.00 |
124,250.00 |
| CRS code |
% |
|
Infectious disease control
(12250)
|
100.0
|